Clinical Impact of New Data From HIVR4P 2021 Virtual

January 27-28 and February 3-4, 2021
In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important conference, including clinical data on new PrEP options, implementation strategies, multipurpose prevention technologies, and an emerging treatment.
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Kenneth Mayer, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 518 KB
Released: February 17, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

Related Content

CCO expert commentary on key studies from HIVR4P // Virtual 2021 on PrEP, implementation strategies, multipurpose prevention technologies, and more

Kenneth Mayer, MD Released: February 25, 2021

Download CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV experiencing treatment failure

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Expert commentary on managing a TB outbreak in a socially and medically complex population of patients living with HIV

Nicky Mehtani, MD, MPH Released: February 22, 2021

CCO video featuring a discussion between Dr. Princy Kumar and Dr. Brian Wood on assessing virologic failure in a heavily treatment-experienced patient

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue